Pfizer CEO Cancels Meeting with German Chancellor, Questions Investments Amid Sector Criticism

Pfizer's CEO has canceled a meeting with German Chancellor Olaf Scholz and is questioning future investments in Germany. This action follows two halted major investments and growing criticism of cost-saving measures within the pharmaceutical sector.